和多醇基物质和心血管疾病:一种机械学和流行病学合成
Xiaoxi Yang1, Xuemei Li2, Xingqiang Li3
1Department of Cardiovascular, the First Affiliated Hospital of China Medical University, Shenyang, China.
Ecotoxicology and environmental safety
|March 14, 2026
概括
和多醇基物质 (PFAS) 是持久性污染物,与心血管风险增加有关. 本综述综合了关于PFAS暴露,心血管疾病和潜在机制的证据.
科学领域:
- 环境健康科学 环境健康科学
- 毒理学 毒理学 毒理学
- 心血管医学 心血管医学
背景情况:
- 和多醇基物质 (PFAS) 是广泛存在的环境污染物.
- 越来越多的证据将PFAS暴露与不良心血管结果联系在一起.
- 现有的审查缺乏对心血管疾病 (CVD) 机制的专注综合.
研究的目的:
- 提供对PFAS暴露和心血管疾病的综合性,以机制为重点的审查.
- 整合暴露科学,流行病学和机械毒理学的发现.
- 确定与PFAS相关的心血管风险的潜在缓解策略.
主要方法:
- 对流行病学,临床和实验研究进行系统的文献搜索 (至2025年11月).
- 包括关于传统和新兴PFAS的研究,评估各种心血管终点.
- 从生物标志物,水污染和混合物建模中分析暴露数据.
主要成果:
- PFAS暴露与血压升高,高血压风险和妊娠高血压疾病之间存在一致的关联.
- 有证据表明内皮功能受损,动脉内膜介质厚度增加,心血管疾病发病率/死亡率更高.
- 融合的机械路径包括氧化应激,炎症,脂质失调和-血管素系统的激活.
结论:
- 通过多种机制性途径,PFAS暴露对心血管健康构成重大威胁.
- 脆弱人群对PFAS诱导的心血管影响的敏感性增加.
- 这一审查支持公共卫生政策,临床风险评估和关于PFAS的监管行动.
更多相关视频
相关概念视频
Psychoneuroimmunology: Cardiovascular Disease
652
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
652
Coronary Artery Disease I: Introduction
1.5K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Atherosclerosis III: Management
562
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Coronary Artery Disease II: Pathophysiology
873
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
873
Peripheral Artery Disease I: Introduction
553
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
553
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
688
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
688


